ArticleTropical animal health and production2026
Influence of dietary Spirulina platensis powder individually or in combination with mannan oligosaccharide on growth performance, serum metabolites, and gut health of broiler chickens exposed to aflatoxin B1.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the efficacy of dietary supplementation with Spirulina platensis powder (SP), both individually and in combination with mannan oligosaccharide (MOS), on the growth performance, serum metabolites, and gut health of broiler chickens exposed to aflatoxin B1 (AFB1). A total of 450 male broiler chickens (ROSS 308) were randomly allocated into one of six treatment groups with fifteen broilers per each. Experimental groups were: negative control (NC, no additives), positive control (PC, exposure to AFB1 without additives), PC + toxin binder (TB, 0.5 g/kg), PC + SP (3 g/kg), PC + MOS (2 g/kg), and PC + (SP + MOS). The experimental period lasted for 42 days. The SP + MOS combination improved feed conversion ratio compared to the PC and TB groups (p < 0.05). In serum metabolites, the positive control (PC) group exhibited significantly decreased glucose and increased triglyceride concentrations compared with the other dietary treatments (p < 0.05). Furthermore, the liver enzymes activity including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were influenced by the treatments (p < 0.05). A significant increase in Lactobacillus counts was observed in the MOS and SP+MOS groups (p < 0.05). Also, dietary supplementation with SP+MOS improved villus surface area in broilers (p < 0.05). In conclusion, addition of SP and MOS, particularly in combination, can mitigate the adverse effects of aflatoxin B1 in broiler chickens.
Indexed as
Identifiers
42257813What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.